Skip to main content
My Consumer Finance

Medicare Part D coverage gap (donut hole): ended for 2025+ vs the old gap

Medicare Part D coverage gap (donut hole): how the old gap worked, why it ended for 2025+ plan years, and how to compare plan EOBs under the yearly Rx OOP cap.

For years, people called Medicare’s Part D coverage gap the “donut hole”: after you and your plan spent past an initial coverage limit, you paid a much higher share of drug costs until you hit catastrophic coverage. Under the Inflation Reduction Act path, that coverage-gap stage ended for 2025 and later plan years. Part D now runs more like deductible → initial coverage → a yearly out-of-pocket cap for covered drugs (figures change by calendar year; confirm on Medicare.gov), with manufacturer and plan liability shifting in ways that matter when you compare plan finders. Older EOBs may still show gap-stage labels from pre-2025 years.

This guide is a consumer map, not a substitute for the official Medicare & You handbook. Drug coverage basics: What is prescription drug coverage. Advantage plan medical OOP caps are a different bucket: Medicare Advantage MOOP basics. Medigap does not generally fill Part D the way it fills Parts A/B gaps: What is Medigap.

Old gap vs redesigned shape (plain English)

Era / ideaWhat shoppers felt at the pharmacyWhat to verify for your year
Classic “donut hole”After initial coverage, you paid a large % of negotiated price until catastrophicHistorical context only for older EOBs
Closing / discount yearsBrand/generic discounts inside the gap reduced the shock but did not erase stagesRead the Explanation of Benefits stage labels
2025+ (gap ended)No classic donut-hole stage; yearly Part D OOP cap for covered drugs (confirm the dollar figure for your plan year)Confirm the plan year on Medicare.gov and your Annual Notice of Change; do not treat the gap as a pending 2026-only redesign

Exact dollar caps, TruOOP (true out-of-pocket) definitions, and manufacturer discount mechanics change by year. Treat any blog number as stale until you match it to CMS materials for the enrollment year you are shopping.

What still drives your bill inside Part D

  1. Formulary and tier, preferred generics vs specialty coinsurance (Formulary exception when a drug is non-formulary).
  2. Deductible, some plans still have a Part D deductible before copays kick in.
  3. Pharmacy network, preferred mail order (Express Scripts, OptumRx, CVS Caremark channels) vs retail.
  4. IRMAA, higher-income surcharges are separate from the donut-hole story; they change your premium, not the stage chart alone.
  5. Medicare Advantage vs standalone PDP, drug stages live in Part D either way; medical MOOP does not pay your Rx coinsurance.

Named anchors in this space include CMS, Medicare.gov Plan Finder, Social Security (for IRMAA), and major Part D / MA-PD sponsors such as UnitedHealthcare, Humana, CVS/Aetna, and Kaiser Permanente plan menus - always compare the specific contract ID, not the parent brand alone.

Worked example: specialty fill across stages

Morgan takes a specialty oral drug with a $1,200/month negotiated price. In an older pre-2025 gap-heavy year, Morgan’s EOB might show months of low copays, then several months of hundreds of dollars in the coverage gap, then catastrophic coinsurance. For 2025+ plan years (gap ended; yearly Rx OOP cap applies - confirm the current CMS dollar figure), Morgan’s planner goal shifts from “will I fall in the hole in August?” to “when do I hit the yearly Rx OOP maximum, and which plan’s deductible + tiers get me there with less cash up front?”

Morgan compares two PDPs on Medicare.gov: Plan A has a $0 Rx deductible but specialty coinsurance of 30%; Plan B has a modest deductible and a preferred specialty tier copay. Morgan lists every NDC, runs Plan Finder, and prints the estimated annual cost - not just the premium. For non-Medicare drug math on an employer plan, the same formulary discipline in Prescription drug coverage still applies.

Shopping moves that still matter

  • Use Medicare.gov Plan Finder with your full drug list every Open Enrollment.
  • Read the Annual Notice of Change - gap/OOP redesigns show up as new stage charts.
  • Ask the pharmacist which stage the claim adjudicated to on the receipt/EOB (Medical bills and insurance).
  • Do not assume Medigap or Advantage MOOP covers Part D patient share.
  • Manufacturer copay cards often cannot be used with federal programs the way they work on commercial insurance - verify.

Checklist

  1. Confirm which calendar year rules apply to the card in your wallet.
  2. Enter every drug and pharmacy into Plan Finder before you renew on autopilot.
  3. Note deductible, tiers, and estimated total annual drug cost - not premium alone.
  4. Watch AOBs/EOBs for stage labels so a spike is not a mystery.
  5. Separate IRMAA premium questions from yearly Rx OOP-cap questions.
  6. Re-check specialty prior auth before a January 1 plan switch.

Part D IRMAA surcharges are separate from coverage-gap cost-sharing: Medicare IRMAA basics.

CMS star ratings for MA-PD and PDP contracts when you compare drug plans: Medicare Advantage star ratings basics.

Educational only. Not Medicare counseling, insurance, or medical advice. Part D parameters change by statute and CMS guidance; verify figures in current Medicare publications and your plan documents.